Clear Harbor Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $293K | Buy |
2,101
+20
| +1% | +$2.8K | 0.02% | 366 |
|
|
2025
Q4 | $255K | Buy |
+2,081
| New | +$253K | 0.02% | 383 |
|
|
2025
Q2 | – | Sell |
-1,825
| Closed | -$204K | – | 420 |
|
|
2025
Q1 | $204K | Buy |
+1,825
| New | +$188K | 0.02% | 369 |
|
|
2023
Q4 | – | Sell |
-4,774
| Closed | -$358K | – | 384 |
|
|
2023
Q3 | $358K | Sell |
4,774
-230
| -5% | -$17.7K | 0.04% | 245 |
|
|
2023
Q2 | $386K | Buy |
5,004
+297
| +6% | +$23.7K | 0.04% | 247 |
|
|
2023
Q1 | $391K | Buy |
4,707
+1,813
| +63% | +$150K | 0.04% | 271 |
|
|
2022
Q4 | $248K | Buy |
+2,894
| New | +$229K | 0.03% | 292 |
|
|
2020
Q4 | – | Sell |
-2,077
| Closed | -$131K | – | 472 |
|
|
2020
Q3 | $131K | Sell |
2,077
-7,500
| -78% | -$520K | 0.02% | 288 |
|
|
2020
Q2 | $737K | Sell |
9,577
-2,500
| -21% | -$192K | 0.14% | 118 |
|
|
2020
Q1 | $903K | Buy |
12,077
+10,132
| +521% | +$700K | 0.21% | 86 |
|
|
2019
Q4 | $126K | Sell |
1,945
-7,354
| -79% | -$479K | 0.02% | 309 |
|
|
2019
Q3 | $589K | Buy |
9,299
+410
| +5% | +$26.8K | 0.12% | 129 |
|
|
2019
Q2 | $601K | Sell |
8,889
-770
| -8% | -$50.7K | 0.12% | 124 |
|
|
2019
Q1 | $628K | Sell |
9,659
-546
| -5% | -$36.3K | 0.13% | 121 |
|
|
2018
Q4 | $638K | Sell |
10,205
-410
| -4% | -$28.7K | 0.15% | 107 |
|
|
2018
Q3 | $728K | Sell |
10,615
-631
| -6% | -$47.7K | 0.15% | 113 |
|
|
2018
Q2 | $797K | Sell |
11,246
-130
| -1% | -$9.18K | 0.15% | 111 |
|
|
2018
Q1 | $858K | Buy |
11,376
+181
| +2% | +$14.4K | 0.17% | 102 |
|
|
2017
Q4 | $802K | Sell |
11,195
-507
| -4% | -$38.5K | 0.15% | 104 |
|
|
2017
Q3 | $948K | Sell |
11,702
-36,180
| -76% | -$2.77M | 0.19% | 96 |
|
|
2017
Q2 | $3.34M | Buy |
47,882
+16,555
| +53% | +$1.1M | 0.64% | 44 |
|
|
2017
Q1 | $2.13M | Buy |
31,327
+8,965
| +40% | +$630K | 0.43% | 60 |
|
|
2016
Q4 | $1.6M | Buy |
22,362
+3,820
| +21% | +$284K | 0.34% | 70 |
|
|
2016
Q3 | $1.47M | Sell |
18,542
-15,828
| -46% | -$1.29M | 0.32% | 75 |
|
|
2016
Q2 | $2.87M | Buy |
34,370
+19,297
| +128% | +$1.71M | 0.62% | 40 |
|
|
2016
Q1 | $1.39M | Buy |
15,073
+3,635
| +32% | +$328K | 0.3% | 69 |
|
|
2015
Q4 | $1.16M | Sell |
11,438
-3,760
| -25% | -$391K | 0.26% | 77 |
|
|
2015
Q3 | $1.49M | Buy |
15,198
+45
| +0.3% | +$5K | 0.34% | 64 |
|
|
2015
Q2 | $1.77M | Buy |
15,153
+15
| +0.1% | +$1.64K | 0.35% | 69 |
|
|
2015
Q1 | $1.49M | Buy |
15,138
+4,780
| +46% | +$485K | 0.29% | 82 |
|
|
2014
Q4 | $976K | Buy |
10,358
+1,214
| +13% | +$126K | 0.2% | 100 |
|
|
2014
Q3 | $973K | Buy |
9,144
+1,044
| +13% | +$102K | 0.22% | 92 |
|
|
2014
Q2 | $672K | Buy |
+8,100
| New | +$630K | 0.14% | 105 |
|
Other funds holding GILD
VCM
VPM
Clear Harbor Asset Management's GILD Position: Q1 2026 in Review
Clear Harbor Asset Management increased its Gilead Sciences (GILD) stake by 0.96% in Q1 2026, buying an estimated $2.8K and bringing the position to 2,101 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #366.
Clear Harbor Asset Management first reported a position in GILD in Q2 2014 and has held it in 33 quarters since. The position peaked at $3.34M in Q2 2017. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Clear Harbor Asset Management held 2,101 shares of Gilead Sciences worth $293K as of Q1 2026.
- Clear Harbor Asset Management bought 20 Gilead Sciences shares in Q1 2026, an estimated $2.8K.
- Gilead Sciences made up 0.02% of Clear Harbor Asset Management's portfolio in Q1 2026, its #366 holding.
- Clear Harbor Asset Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 33 quarters since.
- Clear Harbor Asset Management's Gilead Sciences position peaked at $3.34M in Q2 2017.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Clear Harbor Asset Management's 13F filing for Q1 2026, filed 5 May 2026.